Literature DB >> 18802727

Decision making and quality of life in the treatment of cancer: a review.

S Yousuf Zafar1, Stewart C Alexander, Kevin P Weinfurt, Kevin A Schulman, Amy P Abernethy.   

Abstract

INTRODUCTION: Complexity in decision making for cancer treatment arises from many factors. When considering how to treat patients, physicians prioritize factors such as stage of disease, patient age, and comorbid illnesses. However, physicians must balance these priorities with the patient's preferences, quality of life, social responsibilities, and fear of uncertainty. Although these factors are important, physicians are often unable to effectively judge their patients' preferences. Patients are often unable to fully understand their prognoses and the treatment intent. DISCUSSION: These differences influence how patients and physicians make treatment-related decisions. Partially due to these differences, patients are initially more likely than their physicians to accept greater risk for lesser benefit from treatment. As time progresses and as they experience treatment, a patient's preference changes, yet little is known about this process since few studies have examined it in a prospective longitudinal manner. We present an overview of the literature related to patient and physician decision making and quality of life in patients with advanced cancer, and we propose approaches to future decision-making models in cancer treatment.

Entities:  

Mesh:

Year:  2008        PMID: 18802727     DOI: 10.1007/s00520-008-0505-2

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  60 in total

1.  The SUPPORT study. Introduction.

Authors:  D J Murphy; L E Cluff
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

2.  Preoperative carcinoembryonic antigen predicts outcomes in node-negative colon cancer patients: a multivariate analysis of 572 patients.

Authors:  L E Harrison; J G Guillem; P Paty; A M Cohen
Journal:  J Am Coll Surg       Date:  1997-07       Impact factor: 6.113

3.  Age and adjuvant chemotherapy use after surgery for stage III colon cancer.

Authors:  D Schrag; L D Cramer; P B Bach; C B Begg
Journal:  J Natl Cancer Inst       Date:  2001-06-06       Impact factor: 13.506

4.  Stage III colon cancers: why adjuvant chemotherapy is not offered to elderly patients.

Authors:  T Mahoney; Y H Kuo; A Topilow; J M Davis
Journal:  Arch Surg       Date:  2000-02

5.  Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer.

Authors:  Arnold L Potosky; Linda C Harlan; Richard S Kaplan; Karen A Johnson; Charles F Lynch
Journal:  J Clin Oncol       Date:  2002-03-01       Impact factor: 44.544

6.  What matters to seriously ill older persons making end-of-life treatment decisions?: A qualitative study.

Authors:  Terri R Fried; Elizabeth H Bradley
Journal:  J Palliat Med       Date:  2003-04       Impact factor: 2.947

7.  Desire for information and involvement in treatment decisions: elderly cancer patients' preferences and their physicians' perceptions.

Authors:  Elena B Elkin; Susie H M Kim; Ephraim S Casper; David W Kissane; Deborah Schrag
Journal:  J Clin Oncol       Date:  2007-11-20       Impact factor: 44.544

8.  The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer.

Authors:  Cary P Gross; Gail J McAvay; Zhenchao Guo; Mary E Tinetti
Journal:  Cancer       Date:  2007-06-15       Impact factor: 6.860

9.  Someone to live for: social well-being, parenthood status, and decision-making in oncology.

Authors:  S B Yellen; D F Cella
Journal:  J Clin Oncol       Date:  1995-05       Impact factor: 44.544

10.  Outcomes of Veterans Affairs patients older than age 80 after surgical procedures for colon malignancies.

Authors:  Liz Lee; Madhukaran Jannapureddy; Daniel Albo; Samir S Awad; Buckminster Farrow; Charles C Bellows; David H Berger
Journal:  Am J Surg       Date:  2007-11       Impact factor: 2.565

View more
  37 in total

Review 1.  Non-clinical influences on clinical decision-making: a major challenge to evidence-based practice.

Authors:  F M Hajjaj; M S Salek; M K A Basra; A Y Finlay
Journal:  J R Soc Med       Date:  2010-05       Impact factor: 5.344

2.  Health-related quality of life with adjuvant docetaxel- and trastuzumab-based regimens in patients with node-positive and high-risk node-negative, HER2-positive early breast cancer: results from the BCIRG 006 Study.

Authors:  Heather-Jane Au; Wolfgang Eiermann; Nicholas J Robert; Tadeusz Pienkowski; John Crown; Miguel Martin; Marek Pawlicki; Arlene Chan; John Mackey; John Glaspy; Tamás Pintér; Mei-Ching Liu; Tommy Fornander; Sandeep Sehdev; Jean-Marc Ferrero; Valerie Bée; Maria J Santana; Dave P Miller; Deepa Lalla; Dennis J Slamon
Journal:  Oncologist       Date:  2013-06-28

3.  Decision-making processes among men with low-risk prostate cancer: A survey study.

Authors:  Richard M Hoffman; Stephen K Van Den Eeden; Kimberly M Davis; Tania Lobo; George Luta; Jun Shan; David Aaronson; David F Penson; Amethyst D Leimpeter; Kathryn L Taylor
Journal:  Psychooncology       Date:  2017-07-13       Impact factor: 3.894

Review 4.  Shining light on advanced NSCLC in 2017: combining immune checkpoint inhibitors.

Authors:  Meng Qiao; Tao Jiang; Caicun Zhou
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

5.  American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options.

Authors:  Lowell E Schnipper; Nancy E Davidson; Dana S Wollins; Courtney Tyne; Douglas W Blayney; Diane Blum; Adam P Dicker; Patricia A Ganz; J Russell Hoverman; Robert Langdon; Gary H Lyman; Neal J Meropol; Therese Mulvey; Lee Newcomer; Jeffrey Peppercorn; Blase Polite; Derek Raghavan; Gregory Rossi; Leonard Saltz; Deborah Schrag; Thomas J Smith; Peter P Yu; Clifford A Hudis; Richard L Schilsky
Journal:  J Clin Oncol       Date:  2015-06-22       Impact factor: 44.544

6.  Chemotherapy use and patient treatment preferences in advanced colorectal cancer: a prospective cohort study.

Authors:  S Yousuf Zafar; Jennifer L Malin; Steven C Grambow; David H Abbott; Jane T Kolimaga; Leah L Zullig; Jane C Weeks; John Z Ayanian; Katherine L Kahn; Patricia A Ganz; Paul J Catalano; Dee W West; Dawn Provenzale
Journal:  Cancer       Date:  2012-09-12       Impact factor: 6.860

7.  A theory-based decision aid for patients with cancer: results of feasibility and acceptability testing of DecisionKEYS for cancer.

Authors:  Patricia J Hollen; Richard J Gralla; Randy A Jones; Christopher Y Thomas; David R Brenin; Geoffrey R Weiss; Anneke T Schroen; Gina R Petroni
Journal:  Support Care Cancer       Date:  2012-10-11       Impact factor: 3.603

8.  Long-term disease-specific functioning among prostate cancer survivors and noncancer controls in the prostate, lung, colorectal, and ovarian cancer screening trial.

Authors:  Kathryn L Taylor; George Luta; Anthony B Miller; Timothy R Church; Scott P Kelly; Larry R Muenz; Kimberly M Davis; David L Dawson; Sara Edmond; Douglas Reding; Jerome E Mabie; Thomas L Riley
Journal:  J Clin Oncol       Date:  2012-06-25       Impact factor: 44.544

9.  Patient characteristics associated with the level of patient-reported care coordination among male patients with colorectal cancer in the Veterans Affairs health care system.

Authors:  George L Jackson; Leah L Zullig; Sean M Phelan; Dawn Provenzale; Joan M Griffin; Steven B Clauser; David A Haggstrom; Rahul M Jindal; Michelle van Ryn
Journal:  Cancer       Date:  2015-03-17       Impact factor: 6.860

10.  Patient preferences in advanced or recurrent ovarian cancer.

Authors:  Laura J Havrilesky; Angeles Alvarez Secord; Jessie A Ehrisman; Andrew Berchuck; Fidel A Valea; Paula S Lee; Stephanie L Gaillard; Greg P Samsa; David Cella; Kevin P Weinfurt; Amy P Abernethy; Shelby D Reed
Journal:  Cancer       Date:  2014-08-04       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.